SCHEMBL6730882

SCHEMBL6730882

CCOC(=O)CCC1CN(C(=O)OC(C)(C)C)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
RECQL P46063 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PARP1 P09874 2/20 0.38
KAT7 O95251 1/20 0.38
NR1H2 P55055 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 1/20 0.37
ATM Q13315 2/20 0.36
TSHR P16473 2/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4844477 0.93 ALDH1A1 (0.39) ALDH1A1KDM4EGLAHPGDRECQL
SCHEMBL16846247 0.90 PARP1 (0.37) ALDH1A1KDM4EGLAHPGDRECQL
SCHEMBL21722174 0.87 PARP1 (0.39) ALDH1A1KDM4EGLAHPGDRECQL
SCHEMBL4844498 0.86 PARP1 (0.36) ALDH1A1KDM4EGLAHPGDRECQL
SCHEMBL31376622 0.85 PARP1 (0.57) PARP1NR1H2TSHRSMN1; SMN2
SCHEMBL31377274 0.84 PARP1 (0.41) ALDH1A1HPGDHSD17B10PARP1KAT7
SCHEMBL4846080 0.82 MEN1 (0.41) ALDH1A1HPGDHSD17B10PARP1KAT7
SCHEMBL6350025 0.82 ATM (0.47) ALDH1A1KDM4EGLAHPGDRECQL
SCHEMBL16551790 0.82 ATM (0.47) ALDH1A1KDM4EGLAHPGDRECQL
SCHEMBL6921210 0.82 ATM (0.47) ALDH1A1KDM4EGLAHPGDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6747023-B1 INHIBITORS FOR ACTIVATED COAGULATION FACTOR X, COAGULATION SUPPRESSORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-06-08 US disclosed
US-20040082611-A1 Anticoagulants; brain disorders; respiratory system disorders; side effect reduction DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-04-29 US disclosed
EP-1104754-A1 NOVEL SULFONYL DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-06-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082611-A1 Anticoagulants; brain disorders; respiratory system disorders; side effect reduction F2, CYC1, SULT2A1 ALDH1A1 1316/4885KDM4E 3346/4885GLA 1751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.